Second Sight Medical Products, Inc. (EYES) |
4.14 -0.22 (-5.05%) 08-31 00:00 |
Open: | 4.34 |
High: | 4.35 |
Low: | 4.14 |
Volume: | 35,771 |
Market Cap: | 210(M) |
PE Ratio: | 0 |
Exchange: | NASDAQ Capital Market |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 4.35 |
Resistance 1: | 4.27 |
Pivot price: | 4.14 |
Support 1: | 4.14 |
Support 2: | 3.44 |
52w High: | |
52w Low: |
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
EPS | -0.723 |
Book Value | -0.030 |
PEG Ratio | 0.00 |
Gross Profit | 0.003 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | -10.7 |
Return on Equity (ttm) | -19.0 |
Fri, 18 Oct 2024
Bionic Eye Market to Reach US$ 524 Million by 2032 - Market.us Media
Wed, 29 Nov 2023
Second Sight's Argus II Bionic Eye Approved for Medicare Codes - Medical Device and Diagnostic industry
Thu, 01 Sep 2022
Second Sight Medical Products completes merger with Nano Precision Medical; and changes name to Vivani Medical - Optics.org
Tue, 30 Aug 2022
Second Sight merges with Nano Precision, rebrands as Vivani - Drug Delivery Business
Tue, 30 Aug 2022
Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc. - Business Wire
Fri, 18 Feb 2022
Patients With Bionic Eyes Fear for Sight As Company Discontinues Technology - Newsweek
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |